Other Streetwise ReportsThe Gold Report The Energy Report The Life Sciences Report The Mining Report
Today's Featured Company
Aethlon Medical Inc.: (AEMD:NASDAQ) Aethlon Medical Inc. creates affinity biofiltration devices to treat life-threatening diseases. The company's lead therapeutic candidate is the Aethlon Hemopurifier, a first-in-class device that targets the rapid elimination of infectious viruses and cancer-promoting exosomes from the circulatory system of treated individuals. More >
Streetwise Expert Interviews
Play the Gap to Profit from Australia's Undervalued Biotech Gems: John Hester of Bell Potter Securities
Investors who lament missing the U.S. biotech bull market might have another avenue to pursue. Biotech valuations in Australia are not in sync with U.S. biotech valuations, and comparable stocks from Down Under may have extraordinary technology platforms and huge upside potential. In this interview with The Life Sciences Report, Senior Healthcare Analyst John Hester of Bell Potter Securities discusses two hidden Australian biotech gems, one of which could ride the coattails of a U.S.-based product on a very positive regulatory path.(7/22/15) More >
Brian Marckx of Zacks Investment Research describes changes in regulations affecting the medical device and diagnostics industries, and identifies innovative companies poised to make the most of the situation. (7/15/15) More >
Learn More About Companies in This Issue
|Alliance for Regenerative Medicine|
BrainStorm Cell Therapeutics Inc.
RepliCel Life Sciences Inc.
|Nobilis Health Corp.|
|Aethlon Medical Inc.|